Sofia, Bulgaria, May 21, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Sequrities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for April 2024 the Company recorded an increase in sales of 58% compared to the same month of the previous year, incl. 55% an increase in domestic sales and 60% increase in export sales.

From the beginning of 2024, the Company recorded an increase in sales of 3%, incl. 11% an increase of domestic sales and 2% decrease in export sales.